1-155235252-A-G

Variant summary

Our verdict is Pathogenic. The variant received 15 ACMG points: 16P and 1B. PS3PM5PP2PP3PP5_Very_StrongBP4

The NM_000157.4(GBA1):​c.1448T>C​(p.Leu483Pro) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic,risk factor (★★). ClinVar reports functional evidence for this variant: "SCV002058438: "Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product." PMID:15146461, 28969384" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L483R) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 25)
Exomes 𝑓: 0.000084 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

GBA1
NM_000157.4 missense

Scores

8
6
3

Clinical Significance

Pathogenic; risk factor criteria provided, multiple submitters, no conflicts P:44O:5

Conservation

PhyloP100: 7.95

Publications

1188 publications found
Variant links:
Genes affected
GBA1 (HGNC:4177): (glucosylceramidase beta 1) This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]
GBA1 Gene-Disease associations (from GenCC):
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Gaucher disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • Gaucher disease perinatal lethal
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, G2P
  • late-onset Parkinson disease
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Gaucher disease type I
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • Gaucher disease type II
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Gaucher disease type III
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 15 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV002058438: "Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product." PMID:15146461, 28969384; SCV002073104: Experimental studies have shown that this missense change affects GBA function (Migdalska-Richards A, et. al., 2017).; SCV004100811: Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product; PMID: 2880291; SCV005419279: "functional in vivo abd in vitro studies have shown that the variant impairs the activity" (PMID: 28969384, 24022302, 8294487); SCV000697583: Functional studies report the variant effect results in decreasing GBA enzyme activity in transfected cells (Alfonso__2004, Malini_2013).; SCV001422763: "In summary, this variant meets criteria to be classified as pathogenic for Gaucher disease in an autosomal recessive manner based on the presence of the variant in affected individuals and in combination with other pathogenic variants, functional studies, and the phenotype of individuals with this variant being highly specific for Gaucher disease."; SCV002107096: "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product (PMID: 8294487; 15146461; 30285649; 28969384) - PS3_moderate."; SCV002768544: "In vitro assays demonstrated 13% residual enzymatic activity." PMID:24022302; SCV000491300: Published functional studies demonstrate a damaging effect indicating that this variant is poorly activated by phosphatidylserine, is unstable and has residual enzyme activity of 5-10% of wild type (Grace et al., 1994; Malini et al., 2014).; SCV000964136: Experimental studies have shown that this missense change affects GBA function (PMID: 8294487, 15146461, 24020503).; SCV002049503: Functional studies in both patient-derived cells and cultured cell lines demonstrate enzymatic activity of the variant protein at <10% of normal (Grace 1994, Ivanova 2018, Montfort 2004). PMID: 8294487. PMID: 30662625. PMID: 15146461.; SCV007107388: "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product."; SCV004120381: Beta-glucosidase residual activity in individuals homozygous and compound heterozygous for this variant is reported below <10% of normal, consistent with Gaucher disease (Ivanova et al. 2018. PubMed ID: 30662625; Tammachote et al. 2013. PubMed ID: 23719189).; SCV002755393: Functional analysis of the L483P mutant protein expressed in HEK293 cells revealed that residual GBA activity was 13% as compared to wild-type (Malini, 2014).
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-155235252-A-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 93449.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 94 curated pathogenic missense variants (we use a threshold of 10). The gene has 3 curated benign missense variants. Gene score misZ: 1.1739 (below the threshold of 3.09). Trascript score misZ: 2.2879 (below the threshold of 3.09). GenCC associations: The gene is linked to late-onset Parkinson disease, Gaucher disease type I, Gaucher disease type III, Gaucher disease type II, Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome, Gaucher disease perinatal lethal, Gaucher disease, Parkinson disease.
PP3
Multiple lines of computational evidence support a deleterious effect 8: AlphaMissense, BayesDel_addAF, BayesDel_noAF, MutationAssessor, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
PP5
Variant 1-155235252-A-G is Pathogenic according to our data. Variant chr1-155235252-A-G is described in ClinVar as Pathogenic|risk_factor. ClinVar VariationId is 4288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.19879305). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000157.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA1
NM_000157.4
MANE Select
c.1448T>Cp.Leu483Pro
missense
Exon 10 of 11NP_000148.2P04062-1
GBA1
NM_001005741.3
c.1448T>Cp.Leu483Pro
missense
Exon 11 of 12NP_001005741.1P04062-1
GBA1
NM_001005742.3
c.1448T>Cp.Leu483Pro
missense
Exon 11 of 12NP_001005742.1P04062-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA1
ENST00000368373.8
TSL:1 MANE Select
c.1448T>Cp.Leu483Pro
missense
Exon 10 of 11ENSP00000357357.3P04062-1
GBA1
ENST00000327247.9
TSL:1
c.1448T>Cp.Leu483Pro
missense
Exon 11 of 12ENSP00000314508.5P04062-1
GBA1
ENST00000948997.1
c.1514T>Cp.Leu505Pro
missense
Exon 12 of 13ENSP00000619056.1

Frequencies

GnomAD3 genomes
AF:
0.000237
AC:
36
AN:
151964
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00130
AC:
324
AN:
250058
AF XY:
0.00124
show subpopulations
Gnomad AFR exome
AF:
0.000739
Gnomad AMR exome
AF:
0.00111
Gnomad ASJ exome
AF:
0.00252
Gnomad EAS exome
AF:
0.00120
Gnomad FIN exome
AF:
0.00195
Gnomad NFE exome
AF:
0.00137
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000842
AC:
123
AN:
1460902
Hom.:
0
Cov.:
32
AF XY:
0.0000798
AC XY:
58
AN XY:
726764
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000120
AC:
4
AN:
33438
American (AMR)
AF:
0.000112
AC:
5
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26118
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39658
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86214
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53362
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000675
AC:
75
AN:
1111332
Other (OTH)
AF:
0.000149
AC:
9
AN:
60338
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.242
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000237
AC:
36
AN:
152080
Hom.:
0
Cov.:
25
AF XY:
0.000256
AC XY:
19
AN XY:
74322
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000434
AC:
18
AN:
41492
American (AMR)
AF:
0.00
AC:
0
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5148
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4808
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
67984
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.289
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00253
Hom.:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00315
AC:
383

ClinVar

ClinVar submissions
Significance:Pathogenic; risk factor
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
10
-
-
Gaucher disease type I (10)
9
-
-
not provided (9)
7
-
-
Gaucher disease (8)
5
-
-
Gaucher disease type II (5)
3
-
-
Gaucher disease type III (3)
2
-
-
Gaucher disease perinatal lethal (3)
2
-
-
Gaucher disease type II;C0268251:Gaucher disease type III;C0752347:Lewy body dementia;C1842704:Gaucher disease perinatal lethal;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I;C3160718:Parkinson disease, late-onset (2)
2
-
-
Parkinson disease, late-onset (3)
1
-
-
Gaucher disease type II;C0268251:Gaucher disease type III;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I (1)
1
-
-
GBA1-related disorder (1)
1
-
-
Lewy body dementia (1)
1
-
-
not specified (1)
-
-
-
Dementia, Lewy body, susceptibility to (1)
-
-
-
Movement disorder;C0234379:Resting tremor;C0242422:Parkinsonian disorder;C0749379:Thoracolumbar scoliosis;C0813217:Hypomimic face (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.60
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.56
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.96
D
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.059
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.20
T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.2
M
PhyloP100
7.9
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-5.0
D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.035
D
Polyphen
0.94
P
Vest4
0.96
MVP
0.94
MPC
2.3
ClinPred
0.10
T
GERP RS
3.2
Varity_R
0.97
gMVP
0.99
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs421016; hg19: chr1-155205043; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.